Reperfusion therapy fails to improve limb ischemia in clinical trial

07/30/2013 | TCTMD.com

The use of controlled reperfusion techniques for patients undergoing surgical revascularization did not improve their recovery from critical limb ischemia in a randomized study of 174 patients conducted in Germany. The study showed that the rates of amputation-free survival after four weeks and one year remained the same between the controlled reperfusion group and those who just had surgery.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD